NCT07373600

Brief Summary

This clinical study aims to evaluate the clinical and radiographic outcomes of delayed dental implant placement following socket preservation using an injectable alloplastic bone graft material. The study will include patients who require tooth extraction and are candidates for implant placement. After tooth extraction, the socket will be preserved using the bone graft material, and dental implants will be placed after a healing period. Clinical and radiographic assessments will be performed to evaluate bone quality, bone height, and implant stability. The goal of this study is to determine the effectiveness of injectable alloplastic bone grafts in maintaining the alveolar ridge and improving the success of delayed implant placement.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
18mo left

Started Jan 2026

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress19%
Jan 2026Nov 2027

First Submitted

Initial submission to the registry

December 2, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

January 1, 2026

Completed
27 days until next milestone

First Posted

Study publicly available on registry

January 28, 2026

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2027

Expected
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2027

Last Updated

January 28, 2026

Status Verified

April 1, 2025

Enrollment Period

1 year

First QC Date

December 2, 2025

Last Update Submit

January 20, 2026

Conditions

Keywords

Dental Implant PlacementAlveolar Ridge Preservation

Outcome Measures

Primary Outcomes (1)

  • Implant stability at the time of delayed implant placement

    Implant stability will be assessed at the time of delayed implant placement using resonance frequency analysis (RFA) to obtain implant stability quotient (ISQ) values. The ISQ readings will be used to evaluate the effect of socket preservation with injectable alloplastic bone graft on implant stability in comparison to sites without grafting.

    At the time of delayed implant placement (approximately 4 to 6 months after tooth extraction)

Study Arms (2)

Control Group

NO INTERVENTION

Extraction sites left to heal naturally without any bone grafting material before delayed implant placement. Dental implants will be placed after the natural healing period, and clinical and radiographic evaluations will be performed to assess ridge dimensions and implant outcomes

Study Group

EXPERIMENTAL

Extraction sockets will be preserved using an injectable alloplastic bone graft material immediately after tooth extraction. After a healing period, delayed implant placement will be performed. Clinical and radiographic measurements will be used to evaluate ridge preservation and implant success.

Device: Injectable Alloplastic Bone Graft

Interventions

Following tooth extraction, socket preservation will be performed using an injectable alloplastic bone graft material composed of biocompatible synthetic components. The material will be placed into the extraction socket to maintain ridge dimensions and promote bone regeneration. After a healing period of several months, delayed implant placement will be performed, and clinical and radiographic evaluations will assess ridge preservation and implant success

Study Group

Eligibility Criteria

Age40 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • · Patient with a previously extracted lower posterior tooth and the socket was preserved with injectable bone graft .

You may not qualify if:

  • Patient with systemic disease affection bone metabolism .
  • Patients with contraindication to surgical treatment.
  • Patients with uncontrolled medical conditions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 2, 2025

First Posted

January 28, 2026

Study Start

January 1, 2026

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

November 1, 2027

Last Updated

January 28, 2026

Record last verified: 2025-04